Skip to content

Evaluation of safety and pharmacokinetic parameters of the PTI5803 product

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512472-35-00
Enrollment
8
Registered
2024-07-08
Start date
2024-07-23
Completion date
2024-10-28
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

None listed

Sponsors

Panntherapi, Eurofins Optimed
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026